DOCSLIB.ORG

Jugular Foramen Lesion Diagnostic Dilemma – Schwannoma Or Paraganglioma: a Case Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Jugular Foramen Lesion Diagnostic Dilemma – Schwannoma Or Paraganglioma: a Case Report CASE REPORT Indonesian Journal of Neurosurgery (IJN) 2019, Volume 2, Number 3: 76-79 P-ISSN.2089-1180, E-ISSN.2302-2914 Jugular foramen lesion diagnostic dilemma – schwannoma or paraganglioma: A case report Sachin Sambhaji Chemate1*, Joy Varghese2, Chandrasekar K2, Shankar Ganesh CV2, Mangaleswaran Balamurugan2 ABSTRACT Introduction: Various anomalies occure in the jugular foramen. jugular foramen into the petrous temporal bone on the left side with The most common lesion within the jugular foramen is the prominent central flow voids. Paraganglioma was suspected and hypervascular glomus jugulare tumour followed by neurogenic Digital Subtraction Angiography was done which showed tumour tumors, predominantly schwannoma. Jugular foramen blush with arteriovenous fistula supplied by stylomastoid artery, schwannoma can also be vascularized and frequently mimics which is branch of occipital artery. Surprisingly, histopathology paraganglioma. after surgical resection revealed schwannoma. Case presentation: We present a case of a 36-year-old woman Conclusion: Prominent central vascularity and arteriovenous who presented with 8 to 10 months history of giddiness and fistula with arterial supply from stylomastoid branch of occipital vertigo, slowly progressive sensorineural hearing loss in left ear, artery can be an unusual presentation for jugular foramen gradually progressive left facial weakness (House Brackman grade schwannomas. We describe architecture of vascualrity of jugular III at the time of admission) and gait ataxia. A magnetic resonance schwannoma and identify stylomastoid branch of occipital artery imaging showed an avidly enhancing extra axial left cerebello- as its prime feeder. pontine angle space occupying lesion extending through the Keywords: jugular foramen schwannoma, paraganglioma Cite This Article: Chemate, S.S., Varghese, J., Chandrasekar, K. Ganesh, S.C.V., Balamuragan, M. 2019. Jugular foramen lesion diagnostic dilemma – schwannoma or paraganglioma: A case report. Indonesian Journal of Neurosurgery 2(3): 76-79. DOI: 10.15562/ijn.v2i3.51 1Resident, Department of INTRODUCTION lesion like paraganglioma but very little information Neurosurgery, Apollo Hospitals, available in literature about the architecture of Chennai A diverse group of vascular anomalies originate in 2 its vascularity and no single feeding artery has Senior Consultant, Department 1-4 the jugular foramen. The most common tumour been identified for schwannoma in literature. The of Neurosurgery, Apollo Hospitals, within the jugular foramen is the hypervascular Chennai aim of this study is to identify the architecture of glomus jugulare tumour followed by neurogenic 5,6 vascularity and blood supply of the jugular foramen tumors, predominantly schwannoma. Less schwannoma. common lesions comprise meningioma, hemangiopericytoma, chondrosarcoma, and CASE PRESENTATION plasmacytoma. Metastases and malignant tumours arising in adjacent anatomic structures We present a case of a 36-year-old lady from (nasopharynx, parotid, and temporal bone) in northern part of India, known case of type II *Corresponding author: advanced stages may spread to the jugular foramen. diabetes. She presented with history of giddiness Sachin Sambhaji Chemate; Schwannomas involving the jugular foramen and vertigo since 10 months, gait imbalance since Resident, Department of are rare neoplasms and very few cases have 8 months with tendency to fall on left side, slowly Neurosurgery, Apollo Hospitals, been reported in the literature.7,8 Usually, it is progressive sensorineural hearing loss in left ear, Chennai; misdiagnosed as acoustic neuroma and the gradually progressive left facial weakness since 3 – 4 [email protected] diagnosis is made perioperatively.9,10 Schwannomas months, difficulty in swallowing liquids and change are relatively avascular but jugular foramen of voice since 1 month. schwannoma is known to be hypervascular On examination she was conscious and oriented. neoplasm. It has significant neurological morbidity There was no papilledema. She had signs of left and mortality.11-13 cerebellar hemisphere dysfunction with left VII Received: 2019-01-22 Paraganglioma is a vascular lesion with the nerve palsy (HB grade III), left ear sensorineural Accepted: 2019-02-03 ascending pharyngeal artery as a main feeder. The hearing loss, dysphagia for liquids and impaired Published: 2019-12-01 jugular foramen schwannoma is also hypervascular left gag reflex suggestive of left IX and X nerve 76 Published by DiscoverSys | IJN 2019; 2(3):Open 76-79 access: | doi: 10.15562/ijn.v2i3.51 https://ina-jns.org/ CASE REPORT impairment. Trapezius and sternocleidomastoid (DSA) which revealed a tumour blush in the muscle bulk was normal but weak on left side. region of jugular foramen which was suggestive Based on history and examinations, jugular of a hypervascular lesion (Figure 2). There was a foramen paraganglioma was suspected. Brain draining vein which was seen before appearance Magnetic Resonance Imaging (MRI) with contrast of tumor blush which was suggestive of an was done which showed an extraaxial mass arteriovenous fistula (Figure 3A and 3B). Only measuring 6.5 x 5.4 x 3.6 cm in left cerebellopontine one isolated feeder of arteriovenous fistula was angle space extending through the jugular foramen identified. In unsubtracted view, the same feeding into the petrous temporal bone on the left side vessel was seen from stylomastoid foramen (Figure which was hypointense on T1W and hyperintense 4B), hence stylomastoid artery (branch of occipital on T2W and FLAIR with heterogeneous contrast artery) was identified as the primary feeder of enhancement with salt and paper appearance lesion and the cause of arteriovenous shunting (Figure 1). (Figure 4A) in this case (and not by the ascending As paraganglioma was considered as first pharyngeal artery which is the known feeder of differential diagnosis and supported by brain MRI glomus jugulare). that was suggestive of a vascular lesion, the patient Arteriovenous shunting seen on DSA was more underwent Digital Subtraction Angiography suggestive of paraganglioma. Hence, we decided performed combined approach with preoperative embolization followed by craniotomy and excision of lesion. Preoperative embolization of feeding vessel was done. Post embolization, there was no tumor blush and fistula was completely obliterated. Patient underwent surgery post embolization. We used combined approach with translabyrynthine petrosectomy with left presigmoid and retrosigmoid craniotomy. Intraoperatively, tumour was highly vascular inspite of preoperative embolization. Complete excision of lesion was done. Figure 1. Brain MRI with GADO showing left cerebellopontine angle space Postoperatively patient had left side sensorineural occupying lesion extending through the jugular foramen into the hearing loss, left facial palsy, and dysphagia. She petrous temporal bone on the left side, showing heterogeneous was discharged on postoperative day 7th with Ryle’s contrast enhancement with salt and paper appearance. tube feeding. She was gradually started on speech and swallowing therapy. Histopathological examination showed fragments of spindle cell lesion composed of predominantly hypercellular areas with elongated bland nuclei and moderate eosinophilic cytoplasm (Antoni A) at places and hypocellular areas containing myxoid (Antoni B) were also seen. Verrocay bodies were evident. Few aggregates of fomy histiocytes and cystic changes were noted. Figure 2. DSA showing tumour blush with arteriovenous fistula. Focal lymphoid infiltrates were evident. Focal degenerative changes were also seen. Variable vascular density were noted composed of both thick and thin walled at foci showing proliferating vessels. This histomorphological features were consistent with schwannoma (WHO grade I) (Figure 5). At 6 month of follow up, brain MRI with contrast showed small residual lesion measuring 1.2 x 1.1 x 0.9 cm (Figure 6) which was managed with single fraction cyberknife therapy. DISCUSSION Figure 3. A) Lateral view showing early filling of draining vein though a In present day, development of medical science fistula, B) Early feeling of draining vein even before appearance of has provided us better understanding of various tumor blush, suggestive of arteriovenous fistula. disease in cerebello-pontine angle and jugular Published by DiscoverSys | IJN 2019; 2(3): 76-79 | doi: 10.15562/ijn.v2i3.51 77 CASE REPORT palsy is not due to mechanical compression but it is because of ischemia due to shunting from stylomastoid branch of occipital artery. Schwannomas are typically described as avascular or hypovascular on angiography. We describe an unusual case of a jugular foramen schwannoma with blood supply from stylomastoid branch of occipital artery. To our knowledge this is the first case reported in the literature to talk about blood supply of jugular schwannoma, though we need more cases to support the evidence. Figure 4. A) Stylomastoid artery feeding the tumour, B) Arrow shows the artery in stylomastoid foramen in unsubstracted view. CONCLUSION Prominent central vascularity and arteriovenous fistula within the tumour can be an unusual presentation of jugular foramen schwannomas. We describe architecture of vascularity of jugular schwannoma and identify stylomastoid branch of occipital artery as its prime feeder. We also propose that the pathophysiology of VII nerve palsy is not Figure 5. HPE showing schwannoma (WHO grade I) due to mechanical compression but it is because of
Load more

Recommended publications
  • Neurofibromatosis Type 2 (NF2)
    International Journal of Molecular Sciences Review Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis Suha Bachir 1,† , Sanjit Shah 2,† , Scott Shapiro 3,†, Abigail Koehler 4, Abdelkader Mahammedi 5 , Ravi N. Samy 3, Mario Zuccarello 2, Elizabeth Schorry 1 and Soma Sengupta 4,* 1 Department of Genetics, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA; [email protected] (S.B.); [email protected] (E.S.) 2 Department of Neurosurgery, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (M.Z.) 3 Department of Otolaryngology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (R.N.S.) 4 Department of Neurology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] 5 Department of Radiology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vestibular schwannomas. Meningiomas are a common primary brain tumor; many NF2 patients suffer from multiple meningiomas. In NF2, patients have mutations in the NF2 gene, specifically with loss of function in a tumor-suppressor protein that has a number of synonymous names, including: Merlin, Neurofibromin 2, and schwannomin. Merlin is a 70 kDa protein that has 10 different isoforms. The Hippo Tumor Suppressor pathway is regulated upstream by Merlin. This pathway is critical in regulating cell proliferation and apoptosis, characteristics that are important for tumor progression.
    [Show full text]
  • Information About Mosaic Neurofibromatosis Type 2 (NF2)
    Information about mosaic Neurofibromatosis type 2 (NF2) NF2 occurs because of a mutation (change) in the NF2 gene. When this change is present at the time of conception the changed gene will be present in all the cells of the baby. When this mutation occurs later in the development of the forming embryo, the baby will go on to have a mix of cells: some with the “normal” genetic information and some with the changed information. This mix of cells is called mosaicism. Approximately half the people who have a diagnosis of NF2 have inherited the misprinted NF2 gene change from their mother or father who will also have NF2. They will have that misprinted gene in all the cells of their body. When they have their children, there will be a 1 in 2 chance of passing on NF2 to each child they have. However about half of people with NF2 are the first person in the family to be affected. They have no family history and have not inherited the condition from a parent. When doctors studied this group of patients more closely they noticed certain characteristics. Significantly they observed that fewer children had inherited NF2 than expected some people in this group had relatively mild NF2 NF2 tumours in some patients tended to grow on one side of their body rather than both sides that when a blood sample was tested to identify the NF2 gene, the gene change could not be found in 30-40% of people This lead researchers to conclude that this group of people were most likely to be mosaic for NF2 i.e.
    [Show full text]
  • Simultaneous Neurofibroma and Schwannoma of the Sciatic Nerve
    Simultaneous Neurofibroma and Schwannoma of the Sciatic Nerve 1 4 1 1 2 3 1 S. A. Sintzoff, Jr.,I.5 W . 0. Bank, · P. A. Gevenois, C. Matos, J. Noterman, J. Flament-Durand, and J. Struyven Summary: The authors report a case of simultaneously occur­ MR imaging was performed on a 0.5-T system (Gyro­ ring neurofibroma and schwannoma of the sciatic nerve and scan T5, Philips Medical Systems, Eindhoven, The Neth­ discuss the complementary aspects of MR and OS. The Schwan­ erlands) using a wrap-around knee surface coil in order to norna was well-defined and showed distal enhancement on better define the relationships between the tumors and the sonographic evaluation, whereas the neurofibroma was ill-de­ nerve. Each tumor was isointense to the normal nerve on fined; both tumors were hypoechoic. Tl- and T2-weighted MR T1-weighted images and hyperintense to it on proton Images revealed similar signal characteristics of the two tumors, density and T2-weighted images (Fig. 2A-2C). After intra­ but Intense enhancement following administration of gadolin­ venous gadolinium-DTPA injection, the distal mass showed ium-DTPA distinguished the schwannoma from the neurofi­ intense enhancement, conserving a thin hypointense border broma. (Fig. 2D). Physical and neurologic examination, MR of the central nervous system and skeletal radiographs failed to Index terms: Nerves, sciatic; Neuroma; Schwannoma demonstrate any additional lesions, permitting the reason­ able exclusion of neurofibromatosis types 1 and 2. Schwannomas and neurofibromas are com­ Surgical exposure demonstrated the two tumors on the external popliteal nerve (Fig. 3). The distal tumor could be (1, mon peripheral nerve neoplasms 2).
    [Show full text]
  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)
    Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma,
    [Show full text]
  • A Case of Cerebral Astroblastoma with Rhabdoid Features : a Cytological, Histological, and Immunohistochemical Study
    Title A case of cerebral astroblastoma with rhabdoid features : a cytological, histological, and immunohistochemical study Yuzawa, Sayaka; Nishihara, Hiroshi; Tanino, Mishie; Kimura, Taichi; Moriya, Jun; Kamoshima, Yuuta; Nagashima, Author(s) Kazuo; Tanaka, Shinya Brain tumor pathology, 33(1), 63-70 Citation https://doi.org/10.1007/s10014-015-0241-5 Issue Date 2016-01 Doc URL http://hdl.handle.net/2115/63975 Rights The final publication is available at link.springer.com Type article (author version) File Information Astroblastoma_yuzawa_HUSCAP.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP Case report A case of cerebral astroblastoma with rhabdoid features: a cytological, histological, and immunohistochemical study Sayaka Yuzawa1, Hiroshi Nishihara2, 3, Mishie Tanino1, Taichi Kimura2, 3, Jun Moriya1, Yuuta Kamoshima4, 5, Kazuo Nagashima6, and Shinya Tanaka1, 2. 1Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan. 2Department of Translational Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. 3Translational Research Laboratory, Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan. 4Sapporo Azabu Neurosurgical Hospital, Sapporo, Japan. 5Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan. 6Higashi Tokushukai Hospital, Sapporo, Japan. Correspondence: Shinya Tanaka Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan. Tel: +81-11-706-5053 Fax: +81-11-706-5902 E-mail: [email protected] 1 Abstract Astroblastoma is a rare neuroepithelial neoplasm of unknown origin, usually occurring in children and young adults. Here we report a case of astroblastoma with uncommon features in an 18-year-old female.
    [Show full text]
  • Multiple Inherited Schwannomas, Meningiomas, and Ependymomas Syndrome in an Adult Patient
    Published online: 2021-05-23 Practitioner Section Multiple Inherited Schwannomas, Meningiomas, and Ependymomas Syndrome in an Adult Patient Abstract Vijay Parshuram Neurofibromatosis type 2 (NF2) is also known as multiple inherited schwannomas, meningiomas, Raturi, and ependymomas (MISME) syndrome. Mutation in NF2 gene is the cause for MISME syndrome. Rahul Singh We are reporting here a case of MISME syndrome with triple tumor in a 30‑year‑old male patient Department of Radiotherapy, who presented with the chief complaints of spastic paraparesis, bowel and bladder incontinence, and King George Medical decreased vision in the right eye. University, Lucknow, Uttar Pradesh, India Keywords: Ependymoma, meningioma, multiple inherited schwannomas, and neurofibromatosis Introduction system shows tone to be normal in the upper limb and power grade 5/5 in the bilateral Neurofibromatosis type 2 (NF2) incidence is upper limb. Tone reduced in bilateral 1 in 33,000 and prevalence is 1 in 60,000.[1,2] lower limbs. Deep tendon reflex was It has no predilection for sex, race, and absent in bilateral lower limbs. Pure‑tone ethnicity, and it is most commonly seen in audiometry showed bilateral sensory neural the second and third decades of life that too deafness, which was more on the right side. most commonly between 16 and 24 years Ophthalmic evaluation was done and was of age.[3] Approximately 50% of cases are suggestive of macular corneal opacity of familial and remaining 50% are sporadic in the left eye and central serous retinopathy nature.[4] NF2 is caused by the mutation in with nystagmus in the right eye. MRI merlin gene, which is located on the long brain with contrast showed a well‑defined arm of chromosome 22 (22q12.2).[5] The enhancing extra‑axial space‑occupying hallmark for the diagnosis of NF2 is bilateral lesion (SOL) at left cerebellopontine (CP) vestibular schwannomas on magnetic angle largest measuring 1.4 cm × 1.2 cm.
    [Show full text]
  • An Intraventricular Schwannoma with Associated Hydrocephalus and Ventricular Entrapment: Acasereport
    THIEME e32 Case Report An Intraventricular Schwannoma with Associated Hydrocephalus and Ventricular Entrapment: ACaseReport Sheilah M. Curran-Melendez1 Melanie Fukui1 William Bivin2 David Oliver-Smith3 1 Department of Radiology, Allegheny Health Network, Address for correspondence Sheilah M. Curran-Melendez, MD, Pittsburgh, Pennsylvania, United States Department of Radiology, Allegheny Health Network, 320 E 2 Department of Pathology, Allegheny Health Network, North Avenue, Pittsburgh, PA 15212, United States Pittsburgh, Pennsylvania, United States (e-mail: [email protected]). 3 Department of Neurosurgery, Allegheny Health Network, Pittsburgh, Pennsylvania, United States J Neurol Surg Rep 2015;76:e32–e36. Abstract Intraventricular schwannomas are rare primary brain tumors, with fewer than 25 cases reportedintheliterature.Here,wepresentthecaseofa20-year-oldmalepatientwitha 2 year history of blurry vision and dysesthesia involving his right occiput and upper neck. Keywords Imaging demonstrated a homogeneously enhancing mass located within the atrium of ► ventricles the right lateral ventricle with associated right lateral ventricular entrapment. Pathology ► brain confirmed the tumor to be an intraventricular schwannoma. Imaging findings, presen- ► schwannoma tation, complications, and treatment options for intraventricular schwannomas are ► hydrocephalus described. Case Presentation temporal horn intraventricular mass, with surrounding white matter edema and dilation of the right lateral ventricle. A 20-year-old male patient without significant medical his- Subsequent evaluation with an enhanced magnetic resonance tory presented to an urgent care facility for the evaluation of imaging (MRI) of the head included T2, T2Ã, fluid-attenuated intermittent blurry vision which had been present for ap- inversion recovery, diffusion-weighted, and T1-unenhanced proximately 2 years. The patient additionally complained of images in the axial plane.
    [Show full text]
  • Hemorrhagic Vestibular Schwannoma: an Unusual Clinical Entity Case Report
    Neurosurg Focus 5 (3):Article 9, 1998 Hemorrhagic vestibular schwannoma: an unusual clinical entity Case report Dean Chou, M.D., Prakash Sampath, M.D., and Henry Brem, M.D. Departments of Neurological Surgery and Neuro-Oncology, The Johns Hopkins Hospital, Baltimore, Maryland Hemorrhagic vestibular schwannomas are rare entities, with only a few case reports in the literature during the last 25 years. The authors review the literature on vestibular schwannoma hemorrhage and the presenting symptoms of this entity, which include headache, nausea, vomiting, sudden cranial nerve dysfunction, and ataxia. A very unusual case is presented of a 36-year-old man, who unlike most of the patients reported in the literature, had clinically silent vestibular schwannoma hemorrhage. The authors also discuss the management issues involved in more than 1000 vestibular schwannomas treated at their institution during a 25-year period. Key Words * acoustic tumor * schwannoma * neuroma * hemorrhage * hemorrhagic vestibular tumor Vestibular schwannomas are the most common tumors found in the cerebellopontine angle (CPA), comprising approximately 80% of all tumors arising in this region. They are usually slow-growing, benign tumors that manifest clinically by directly compressing the neural elements traversing the CPA, including the pons, cerebellum, and the lower cranial nerves. Hemorrhage into a vestibular schwannoma is rare and has been shown to present with acute neurological changes and deterioration. We review the literature on the presenting symptoms of hemorrhagic vestibular schwannomas and describe the case of a man with a large hemorrhagic vestibular schwannoma who presented with signs and symptoms of a slow-growing, insidious compressive lesion. In doing so, we hope to shed light on this unusual clinical entity and discuss management issues.
    [Show full text]
  • Cervical Intramedullary Schwannoma with Syrinx: Case Report and Review of the Literature
    THIEME Case Report 239 Cervical Intramedullary Schwannoma with Syrinx: Case Report and Review of the Literature Abdulaziz AlQarni1 A. AlArifi1 Ali H. Alassiri1 Amjed Kouli1 M. T. Abbas1 1Department of Neurosurgery, King Abdulaziz Medical City, Address for correspondence Abdulaziz AlQarni, MBBS, Department Saudi Arabia, Riyadh of Surgery, King Abdulaziz Medical City, Ministry of National Guard, P.O. Box: 22490, Riyadh 11426, Saudi Arabia, Riyadh (e-mail: [email protected]). Indian J Neurosurg 2018;7:239–248 Abstract Schwannoma is a nerve sheath tumor originating from the Schwann cell. It is be- nign in nature and it arises from anywhere where Schwann cells can be found. It is rarely found in the parenchyma of the spinal cord. Intramedullary schwannomas (or neurilemmomas) without evidence of neurofibromatosis are rare spinal cord tumors. Intramedullary schwannoma was first reported in 1932 by Penfield. Our patient pre- sented with neck pain, gradually worsening, weakness in the right upper and lower limbs, numbness in both shoulders, and a decrease in the grasping strength of both hands over a 4-year period. A magnetic resonance imaging of the spine showed a heterogeneously enhancing mass in the cervical spinal cord extending from the C2 to T1 levels with associated hemorrhagic changes. Histologically, the tumor was found Keywords to be composed of bland spindle cells with blunt-ended and sometimes wavy nuclei ► intramedullary admixed with hyalinized vasculature. Surrounding reactive spinal cord parenchyma schwannomas with frequent Rosenthal fibers was also observed. Focal Verocay bodies were evident, ► syrinx and with immunohistochemistry, there was diffuse and strong positivity for S100, ► spinal cord tumor which is confirmatory for the diagnosis of schwannoma.
    [Show full text]
  • Current Understanding of Neurofibromatosis Type 1, 2, And
    International Journal of Molecular Sciences Review Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis Ryota Tamura Department of Neurosurgery, Kawasaki Municipal Hospital, Shinkawadori, Kanagawa, Kawasaki-ku 210-0013, Japan; [email protected] Abstract: Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of tumors of the central or peripheral nervous system including the brain, spinal cord, organs, skin, and bones. There are three types of NF: NF1 accounting for 96% of all cases, NF2 in 3%, and schwannomatosis (SWN) in <1%. The NF1 gene is located on chromosome 17q11.2, which encodes for a tumor suppressor protein, neurofibromin, that functions as a negative regulator of Ras/MAPK and PI3K/mTOR signaling pathways. The NF2 gene is identified on chromosome 22q12, which encodes for merlin, a tumor suppressor protein related to ezrin-radixin-moesin that modulates the activity of PI3K/AKT, Raf/MEK/ERK, and mTOR signaling pathways. In contrast, molecular insights on the different forms of SWN remain unclear. Inactivating mutations in the tumor suppressor genes SMARCB1 and LZTR1 are considered responsible for a majority of cases. Recently, treatment strategies to target specific genetic or molecular events involved in their tumorigenesis are developed. This study discusses molecular pathways and related targeted therapies for NF1, NF2, and SWN and reviews recent clinical trials which involve NF patients. Keywords: neurofibromatosis type 1; neurofibromatosis type 2; schwannomatosis; molecular tar- geted therapy; clinical trial Citation: Tamura, R. Current Understanding of Neurofibromatosis Int. Type 1, 2, and Schwannomatosis. 1. Introduction J. Mol. Sci. 2021, 22, 5850. https:// doi.org/10.3390/ijms22115850 Neurofibromatosis (NF) is a genetic disorder that causes multiple tumors on nerve tissues, including brain, spinal cord, and peripheral nerves [1–3].
    [Show full text]
  • Genetic Testing for Neurofibromatosis and Related Disorders
    Corporate Medical Policy Genetic Testing for Neurofibromatosis and Related Disorders AHS – M2134 File Name: genetic_testing_for_neurofibromatosis_and_related_disorders Origination: 01/2019 Last CAPReview: 07/2021 Next CAP Review: 07/2022 Last Review: 07/2021 Description of Procedure or Service Neurofibromatoses are a group of three clinically and genetically distinct disorders that cause tumors to form on nerve tissue. Neurofibromatosis type 1 (NF1) is caused by autosomal dominant mutations in the neurofibromin (NF1) gene and is characterized by multiple café-au-lait macules and neurofibromas (Korf, 2021). Neurofibromatosis type (NF2) is caused by autosomal dominant mutations in the merlin, also known as schwannomin, (NF2) gene, and is characterized by multiple tumors of the nervous system, including the more common bilateral vestibular schwannomas as well as intracranial and spinal meningiomas, intrinsic ependymomas, and other spine tumors (Evans, 2020). Schwannomatosis is caused by inactivating mutations in SMARCB1 and LZTR and is characterized by multiple schwannomas and pain arising in adulthood (Yohay & Bergner, 2019). Legius syndrome is an NF1-like disorder caused by autosomal dominant mutations in the sprout-related EVH1 [enabled/vasodilator-stimulated phosphoprotein homology 1] domain-containing protein 1 (SPRED1) gene, resulting in café-au-lait macules. Constitutional mismatch repair-deficiency syndrome (CMMR-D), caused by mutations in mismatch repair genes, can also result in café-au-lait macules, axillary freckling, and Lisch nodules similar to NF1; however, unlike NF1, CMMR-D can also result in a variety of different malignancies, including glioblastoma and colorectal cancer (Korf, 2021). Related Policies Prenatal Screening AHS-G2035 ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician.
    [Show full text]
  • Use of Calretinin, CD56, and CD34 for Differential Diagnosis of Schwannoma and Neurofibroma
    The Korean Journal of Pathology 2011; 45: 30-35 DOI: 10.4132/KoreanJPathol.2011.45.1.30 Use of Calretinin, CD56, and CD34 for Differential Diagnosis of Schwannoma and Neurofibroma Ji Young Park ∙ Hoon Park1 Background: It is important to differentiate between schwannomas and neurofibromas for the Nam Jo Park ∙ June Sik Park2 cases in which the histopathologic features overlap. Depending on the tumor type, surgeons can Hyun-Jung Sung3 ∙ Sang Sook Lee decide on a treatment method and whether to preserve or sacrifice the nerve; the possibility of malignant transformation in the case of neurofibromas also needs to be considered. Methods: We studied 101 cases of schwannoma and 103 cases of neurofibroma. All the hematoxylin and Department of Pathology, Keimyung University School of Medicine, Daegu; 1Department of eosin slides for these cases were reviewed, and tissue microarrays were prepared from the repre- Otolaryngology, Korea Cancer Center Hospital, sentative areas. Immunohistochemical analysis was performed using antibodies for S-100 pro- Seoul; 2Department of Otolaryngology, tein, calretinin, CD56 and CD34. Results: All the tumors except 3 neurofibromas were positive for Kyungpook National University School of the S-100 protein. Calretinin was found in 26.7% of the schwannomas (27/101), but it was not Medicine; 3Department of Pathology, Catholic found in any of the neurofibromas. CD56 was positive in 77.2% of the schwannomas (78/101) University of Daegu School of Medicine, Daegu, and in 9.8% of the neurofibromas (10/102). CD34 was positive in 42.5% of the schwannomas Korea (43/101) and in 80.2% of the neurofibromas (81/101).
    [Show full text]